Literature DB >> 22528102

Subcutaneous adipose tissue biopsy for amyloid protein studies.

Per Westermark1.   

Abstract

Symptoms from a systemic amyloidosis are usually coming from one of the inner organs, e.g., heart or kidney. However, for diagnosis and for material for amyloid protein studies, biopsy from an easier accessible tissue is preferred. This chapter describes biopsy from subcutaneous adipose tissue as a particularly suitable method to obtain amyloid.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22528102     DOI： 10.1007/978-1-61779-551-0_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  10 in total

Review 1.  Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.

Authors:  Gunilla T Westermark; Marcus Fändrich; Katarzyna Lundmark; Per Westermark
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  A 79-year-old man with unexplained recurrent syncope and severe orthostatic hypotension.

Authors:  Beatrice Laura Montinaro; Viviana Bozzano; Angelica Carandina; Giorgio Alberto Croci; Alessio Di Fonzo; Eleonora Tobaldini
Journal:  Intern Emerg Med       Date:  2021-09-15       Impact factor: 5.472

3.  Educational Case: Orbital B-Cell Lymphoma With Amyloid Deposition.

Authors:  Terrell E Jones; Marie C De Frances; Nidhi Aggarwal
Journal:  Acad Pathol       Date:  2020-07-06

4.  Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.

Authors:  Hedvig Paulsson Rokke; Nima Sadat Gousheh; Per Westermark; Ole B Suhr; Intissar Anan; Elisabet Ihse; Björn Pilebro; Jonas Wixner
Journal:  Orphanet J Rare Dis       Date:  2020-10-08       Impact factor: 4.123

5.  Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis.

Authors:  Intissar Anan; Ole B Suhr; Katarzyna Liszewska; Jorge Mejia Baranda; Björn Pilebro; Jonas Wixner; Elisabet Ihse
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

6.  Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.

Authors:  P Eldhagen; S Berg; L H Lund; P Sörensson; O B Suhr; P Westermark
Journal:  J Intern Med       Date:  2021-01-07       Impact factor: 8.989

Review 7.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

8.  Three cases of systemic amyloidosis successfully diagnosed by subcutaneous fat tissue biopsy of the hip.

Authors:  Masahisa Arahata; Shigeru Shimadoi; Satosi Yamatani; Shin-Ichi Hayashi; Shigeharu Miwa; Hidesaku Asakura; Shinji Nakao
Journal:  Clin Interv Aging       Date:  2016-08-05       Impact factor: 4.458

Review 9.  First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.

Authors:  David Adams; Ole B Suhr; Ernst Hund; Laura Obici; Ivailo Tournev; Josep M Campistol; Michel S Slama; Bouke P Hazenberg; Teresa Coelho
Journal:  Curr Opin Neurol       Date:  2016-02       Impact factor: 5.710

Review 10.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.